Verified peer comparison
Inhibrx Biosciences vs Harvard Ave Acquisition Financial Comparison
Direct answer
Inhibrx Biosciences and Harvard Ave Acquisition are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Inhibrx Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Inhibrx Biosciences Revenue
- 1,300,000 USD
- Harvard Ave Acquisition Revenue
- 0 USD
- Inhibrx Biosciences Operating income
- -135,025,000 USD
- Harvard Ave Acquisition Operating income
- -192 USD